ライフサイエンスコーパス: subconjunctival injection

1 er: suprachoroidal > intravitreal >posterior subconjunctival injection.

2 when compared to intravitreal and posterior subconjunctival injections.

3 Daily subconjunctival injections (0.01-10 pmol/d protein) were

4 of six New Zealand white rabbits was given a subconjunctival injection at the 12-o'clock position wit

5 = 5) 10 weeks of age received two 20-microL subconjunctival injections delivered with a 72-hour inte

6 Subconjunctival injection for each group (XG-102 90 mug,

7 e VEGFR1_MO, STD MO and PBS groups following subconjunctival injection in mice that underwent normal

8 cinolone acetonide, and PBS groups following subconjunctival injection in mice that underwent penetra

9 40 mug) was administered every 3 months as a subconjunctival injection in only one randomly assigned

10 rance of the nanoparticles in the eyes after subconjunctival injection in vivo.

11 Anterior subconjunctival injection led to high, though short-live

12 Subconjunctival injection may be a useful approach for d

13 -inflammatory drug (NSAID) or intraoperative subconjunctival injection of 2 mg triamcinolone acetonid

14 The time course and extent of mydriasis from subconjunctival injection of 2% pirenzepine were determi

15 Patients were administered a single subconjunctival injection of 250 muL XG-102 90 mug (n =

16 The study drug was administered as a single subconjunctival injection of 30 muL (1320 mug) sirolimus

17 eedling with HA-5FU mixture or needling with subconjunctival injection of 5FU solution alone.

18 The right eye of 15 mice received a single subconjunctival injection of a 1.5-microL solution of 0.

19 ed keratitis was significantly reduced after subconjunctival injection of a monoclonal antibody (mAb)

20 nase modulation after AA treatment, a single subconjunctival injection of AA (300 microg) was deliver

21 Conversely, subconjunctival injection of Ab to ICAM-1 did not impair

22 Subconjunctival injection of Ab to PECAM-1 significantly

23 ek-old, LH(BETA)T(AG) mice received a single subconjunctival injection of anecortave acetate (1200, 6

24 ek-old, LH(BETA)T(AG) mice received a single subconjunctival injection of anecortave acetate (600, 30

25 The fellow eye was given a subconjunctival injection of balanced salt solution.

26 Postoperative subconjunctival injection of bevacizumab is associated w

27 Depletion of local macrophages, through subconjunctival injection of clodronate liposome, attenu

28 We induced mast cell degranulation by local subconjunctival injection of compound 48/80.

29 Subconjunctival injection of disodium cromoglycate signi

30 16-week-old mice were treated with a single subconjunctival injection of either anecortave acetate (

31 Subconjunctival injection of HA-5FU to revive bleb funct

32 help prove the concept that subcutaneous and subconjunctival injection of HC-HA/PTX3 is a novel appro

33 Anterior subconjunctival injection of ketorolac produced high int

34 s showed that different suturing techniques, subconjunctival injection of long-acting steroid, and ta

35 CpG DNA, which binds TLR9, was tested after subconjunctival injection of mice with control or CpG DN

36 Subconjunctival injection of mitomycin C in the rabbit p

37 Subconjunctival injection of MMP13i prior to P. aerugino

38 Strikingly, subconjunctival injection of P-IQACRG was very effective

39 In the mouse cornea, subconjunctival injection of the morpholino-inhibited co

40 Dutch-belted rabbits received a subconjunctival injection of triamcinolone acetonide to

41 A single subconjunctival injection of XG-102 at the end of ocular

42 Subconjunctival injections of 0.0002% to 0.2% pirenzepin

43 Subconjunctival injections of 0.002% or less pirenzepine

44 Subconjunctival injections of 0.02% or greater pirenzepi

45 d to receive a postoperative course of seven subconjunctival injections of bevacizumab (1.25 mg, 25 m

46 d to receive a postoperative course of seven subconjunctival injections of CAT-152 (1 mg/mL), 5-FU (5

47 ce was tested by depleting macrophages using subconjunctival injections of clodronate-containing lipo

48 Control mice received two subconjunctival injections of DMSO or of saline solution

49 concentration of 0.2 mg/mL or postoperative subconjunctival injections of either ilomastat or phosph

50 randomly allocated to receive postoperative subconjunctival injections of either phosphate-buffered

51 group of mice of both strains also received subconjunctival injections of exogenous IFN-gamma or veh

52 BETA)T(AG) mice were treated with six serial subconjunctival injections of focally delivered carbopla

53 g, 16-week-old mice were treated with single subconjunctival injections of the selective vascular-tar

54 Cs were selectively depleted by timed local (subconjunctival) injection of diphtheria toxin (DT) into

55 venous delivery than after focal delivery by subconjunctival injection or CCI.

56 oroid, vitreous humor, and optic nerve after subconjunctival injection or iontophoretic carboplatin d

57 ix cycles of 5.0 mg carboplatin delivered by subconjunctival injection or six transscleral carboplati

58 Ketorolac was administered by anterior subconjunctival injection, posterior periocular injectio

59 to prevent corneal graft rejection following subconjunctival injection provided initially during tran

60 It was reported that, after subconjunctival injection, RNA nanoparticles with tri-wa

61 ocal recombinant Gal-1 (rGal-1) treatment by subconjunctival injections significantly diminishes P. a

62 red to the mouse retina and uveal tissues by subconjunctival injection through transscleral diffusion

63 arboplatin was administered through biweekly subconjunctival injections to right eyes only for 3 week

64 either mBD1 or mBD2 small interfering RNA by subconjunctival injection together with topical applicat

65 ic preoperative antibiotics or postoperative subconjunctival injection was associated with a 40% to 5

66 lated-P-IQACRG delivered via intravitreal or subconjunctival injection was demonstrated by avidin-bio

67 on of neutrophil recruitment was achieved by subconjunctival injection with an antibody against macro

68 Infected BALB/c mice also were tested after subconjunctival injection with recombinant murine (rm)ST

69 with HSV-1 were vaccinated periocularly (by subconjunctival injection) with gD1 and adjuvant, gD2 an